Thought Leaders from Burzynski Research Institute Present Encouraging Data on Antineoplastons for Treatment of Malignant Gliomas
11/20/2008 9:42:41 AM
HOUSTON & LAS VEGAS--(BUSINESS WIRE)--Several thought leaders from the Burzynski Research Institute, Inc. (BRI) and the Burzynski Clinic (BC) in Houston, Texas are presenting at the 13th Annual Scientific Meeting of the Society for NeuroOncology. Held in Las Vegas, the international meeting convenes physicians and academia to share knowledge, discuss and advance the treatment of brain tumors. The content presented by BRI is significant as it adds to an expanding body of evidence that suggests certain malignant gliomas to be responsive to antineoplaston therapy.
comments powered by